Parkinson Disease

Future Parkinson Disease Stage May Be Predictable by Present Low HRQOL

September 23rd 2021, 7:30pm

Article

This follow-up study of patients first analyzed 10 years ago sought to determine if health-related quality of life (HRQOL) was still a reliable predictor of Parkinson disease severity, especially at it relates to Hoehn-Yahr stage increase.

Study Explores Effects of OFF Periods in Patients With Parkinson Disease, Care Partners

September 17th 2021, 4:00pm

Article

In interviews with patients with Parkinson disease and their care partners, study authors noted that OFF periods can impair socialization, physical function, leisure activities, driving, and other means of independence.

For Movement Disorders, Palliative Care Remains Challenging

September 10th 2021, 5:45pm

Article

Neuropalliative care is an emerging field for those with conditions such as Parkinson disease, multiple system atrophy, progressive supranuclear palsy, corticobasal syndrome, and other diseases, but access to care remains limited, according to a recent survey.

Safinamide Associated With Pain Improvement in Patients With Parkinson Disease

September 4th 2021, 3:00pm

Article

Results of the SAFINONMOTOR open-label study found that safinamide was safe and effective in improving pain of patients with Parkinson disease at 6 months.

Herbal Tea Consumption May Reduce Nonmotor Symptom Burden in Parkinson Disease

August 30th 2021, 7:10pm

Article

Patients with idiopathic Parkinson disease given Origanum majorana tea in combination with conventional medication exhibited significant improvements in depressive and nonmotor symptom burden vs placebo, although improvement of motor symptoms was not significant.

Latest News in Parkinson Disease: Adapting Telehealth, Differentiating Parkinsonism and Tardive Dyskinesia, and More

August 26th 2021, 1:00pm

Article

An overview of the latest news in Parkinson disease reported across clinical research.

Study Finds Home-Based Postoperative Management of Deep Brain Stimulation Safe, Effective

August 23rd 2021, 8:30pm

Article

Postoperative management of deep brain stimulation in patients with Parkinson disease was shown to be safe and effective when administered at home, which may reduce necessity of in-clinic visits and care access issues.

Latest News in Parkinson Disease: Expectations for 2021 IFN Meeting, Future of Advanced Disease Care, and More

August 21st 2021, 11:15am

Article

An overview of the latest news in Parkinson disease (PD) reported across MJH Life Sciences™.

Pimavanserin Use Linked With Greater Risk of Hospitalization, Mortality in Patients With Parkinson Disease

August 17th 2021, 8:00pm

Article

Pimavanserin (Nuplazid) initiation among patients with Parkinson disease was associated with greater risk of 30-day hospitalization and mortality up to one year compared with non-users.

Latest News in Parkinson Disease: Multidisciplinary Care for Advanced Disease, Fruit Compound Shows Promise, and More

August 14th 2021, 3:30pm

Article

An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.